Recently, in a placebo-controlled clinical trial evaluating the role of curcumin in PCa patients with intermittent androgen deprivation (IAD), though found no significant difference in the curve of off-treatment duration, PSA elevation was significantly suppressed [110]. Here, KLK3 is linked to posterior cortical atrophy.